Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

RePer-AGE: Reorganization of Visuo-cognitive Functions Based on Peripheral Vision With Aging (RePer-AGE)

21 luglio 2026 aggiornato da: University Hospital, Grenoble
The RePer-AGE study investigates how central and peripheral vision contribute to visual recognition and how these mechanisms change with normal aging. The study is based on the hypothesis that peripheral vision provides rapid global information that supports visual recognition through predictive mechanisms. Healthy young adults (18-30 years) and older adults (60-85 years) will undergo visual psychophysical testing, ophthalmological examinations, and, for a subset of participants, functional magnetic resonance imaging (fMRI). The results are expected to improve our understanding of age-related changes in visuo-cognitive functions and provide reference data for future studies on age-related visual disorders.

Panoramica dello studio

Descrizione dettagliata

Visual recognition depends on the complementary contribution of central and peripheral vision. Central vision provides high spatial resolution and supports the detailed analysis required for object identification, whereas peripheral vision rapidly extracts coarse visual information that provides a global representation of the surrounding environment. According to predictive models of visual processing, this early peripheral information is used to generate predictions that facilitate the subsequent processing of detailed visual inputs.

The RePer-AGE project is based on the hypothesis that peripheral vision plays a key role in predictive visual processing and that this contribution changes during normal aging. Although aging is associated with well-documented declines in visual acuity and contrast sensitivity, particularly for high spatial frequencies, several findings suggest that the processing of coarse visual information conveyed by peripheral vision may be relatively preserved. This preserved processing may contribute to compensatory mechanisms supporting visual recognition in older adults.

RePer-AGE is a prospective, monocentric interventional study conducted at Grenoble Alpes University Hospital (CHU Grenoble Alpes) and the Laboratoire de Psychologie et NeuroCognition (LPNC, CNRS, Université Grenoble Alpes). The study will recruit 160 healthy volunteers divided into two age groups: young adults (18-30 years) and older adults (60-85 years). Participants will undergo an ophthalmological examination to ensure normal or corrected-to-normal vision and the absence of ocular disease likely to affect visual performance. Older participants will also complete a brief cognitive screening assessment.

The project combines complementary behavioral, ophthalmological, and neuroimaging approaches to investigate the respective contributions of central and peripheral vision to visual recognition.

The first research axis combines psychophysical experiments with ophthalmological assessments. Participants perform computerized visual recognition tasks specifically designed to evaluate the relative contribution of central and peripheral vision. Additional ophthalmological examinations include automated static perimetry to assess retinal sensitivity across the visual field and low-luminance visual acuity testing. These measurements will allow the relationship between retinal function and visual recognition performance to be investigated.

The second research axis combines psychophysical experiments with functional magnetic resonance imaging (fMRI). During MRI acquisition, participants perform visual recognition tasks while blood oxygen level-dependent (BOLD) activity is recorded. These data will be used to identify the cortical networks supporting predictive visual processing and to determine how these neural mechanisms are modified during normal aging.

The psychophysical paradigms are derived from previous studies conducted by the research team and investigate two complementary aspects of visual recognition. One paradigm evaluates the respective contribution of central and peripheral vision to scene categorization, whereas the second examines how semantic information extracted from peripheral vision influences the recognition of centrally presented visual stimuli through predictive mechanisms.

The primary objective of the study is to determine how central and peripheral vision differentially contribute to visual recognition and how these mechanisms are reorganized with aging. Secondary objectives include characterizing age-related changes in retinal sensitivity, examining the relationship between retinal function and behavioral performance, and identifying the neural correlates of predictive visual processing using functional MRI.

The results of RePer-AGE are expected to improve the understanding of the mechanisms underlying normal visual aging. They will provide normative reference data for future studies investigating pathological aging and visual disorders affecting central vision, and may ultimately contribute to the development of new approaches for visual assessment and rehabilitation.

Tipo di studio

Interventistico

Iscrizione (Stimato)

160

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

    • Isère
      • Grenoble, Isère, Francia, 38043
        • CHU Grenoble Alpes
        • Contatto:
        • Contatto:
        • Investigatore principale:
          • Mathilde Gallice, MD
        • Sub-investigatore:
          • Carole Peyrin, PhD

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

Sì

Descrizione

Inclusion Criteria:

  • Healthy young adults aged 18 to 30 years or healthy older adults aged 60 to 85 years.
  • Normal or corrected-to-normal visual acuity.
  • No ophthalmological disease affecting visual function.
  • For participants aged 60 years or older: Mini-Mental State Examination (MMSE) score ≥23.
  • Affiliated with a national health insurance system.
  • Written informed consent.

Non inclusion Criteria:

  • Individuals protected under French regulations governing research involving human participants.
  • Employees or individuals under the direct authority of the investigators.
  • History of neurological or psychiatric disorders likely to affect visual or cognitive functions.
  • Current treatment likely to alter visual function or vigilance.
  • MRI contraindications (metallic implants, pacemaker, severe claustrophobia, or other MRI safety contraindications) for participation in the MRI arm only.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Scienza basilare
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Psychophysics and Ophthalmology
Participants undergo psychophysical visual recognition tasks together with ophthalmological examinations, including retinal sensitivity assessment by automated perimetry and low-luminance visual acuity testing.
Computerized visual recognition tasks assessing the respective contributions of central and peripheral vision to scene recognition and predictive visual processing.
Ophthalmological examinations including retinal sensitivity (Humphrey automated perimetry) and low-luminance visual acuity.
Sperimentale: Psychophysics and Functional MRI
Participants undergo psychophysical visual recognition tasks while functional magnetic resonance imaging (fMRI) is performed to investigate the neural mechanisms underlying visual recognition and predictive processing.
Computerized visual recognition tasks assessing the respective contributions of central and peripheral vision to scene recognition and predictive visual processing.
Functional MRI performed during psychophysical visual recognition tasks to assess brain activity associated with visual recognition and predictive visual processing.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Behavioral performance during scene categorization tasks
Lasso di tempo: Baseline (single experimental session)
Behavioral performance will be assessed using accuracy and response time during computerized scene categorization tasks evaluating (1) central versus peripheral vision (EXC paradigm) and (2) semantic congruency between peripheral and central vision (VPC paradigm). Comparisons will be performed between young and older adults.
Baseline (single experimental session)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Retinal sensitivity
Lasso di tempo: Baseline
Retinal sensitivity measured by Humphrey 30-2 automated perimetry, including Mean Deviation (MD), Pattern Standard Deviation (PSD), and retinal sensitivity thresholds.
Baseline
Brain activation during visual recognition
Lasso di tempo: Baseline
Blood oxygen level-dependent (BOLD) activity measured by functional magnetic resonance imaging during scene categorization tasks, including whole-brain analyses and regions of interest involved in visual recognition and predictive processing.
Baseline

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 settembre 2026

Completamento primario (Stimato)

1 marzo 2030

Completamento dello studio (Stimato)

1 settembre 2030

Date di iscrizione allo studio

Primo inviato

21 luglio 2026

Primo inviato che soddisfa i criteri di controllo qualità

21 luglio 2026

Primo Inserito (Effettivo)

27 luglio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

27 luglio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

21 luglio 2026

Ultimo verificato

1 luglio 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 38RC25.0395
  • ANR-25-CE28-6333 (Altro numero di sovvenzione/finanziamento: Agence Nationale de la Recherche (ANR))
  • 2026-A00492-49 (Altro identificatore: Agence nationale de sécurité du médicament et des produits de santé (ANSM))

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

De-identified individual participant data necessary to reproduce the results reported in scientific publications will be shared. Data may include demographic, behavioral, ophthalmological, and neuroimaging data after anonymization, in accordance with the study Data Management Plan and applicable data protection regulations.

Periodo di condivisione IPD

IPD and supporting information will be available after publication of the primary study results. Data will remain available for as long as they are maintained in the designated data repository, in accordance with the study Data Management Plan and institutional policies.

Criteri di accesso alla condivisione IPD

De-identified individual participant data will be made available to researchers for scientifically sound research purposes, in accordance with the study Data Management Plan, applicable legal and ethical requirements, and institutional policies.

Tipo di informazioni di supporto alla condivisione IPD

  • STUDIO_PROTOCOLLO
  • CODICE_ANALITICO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi